Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

13.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.1K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
7.0K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reengineering Ponatinib to Minimize Cardiovascular Toxicity.

Cancer research·2022
Same author

High-Frequency Ultrasound Echocardiography to Assess Zebrafish Cardiac Function.

Journal of visualized experiments : JoVE·2020
Same author

Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.

American journal of physiology. Heart and circulatory physiology·2019
Same author

Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.

Biochemistry·2018
Same author

Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils.

Biomolecules·2017
Same author

The thermodynamics of Pr55Gag-RNA interaction regulate the assembly of HIV.

PLoS pathogens·2017
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.4K

Lipids in Amyloid-β Processing, Aggregation, and Toxicity.

Isabel Morgado1, Megan Garvey

  • 1Centre of Marine Sciences, University of Algarve, Faro, Portugal, imorgado@bu.edu.

Advances in Experimental Medicine and Biology
|July 8, 2015
PubMed
Summary
This summary is machine-generated.

Lipids and cholesterol significantly impact amyloid-beta (Aβ) aggregation and clearance, playing a crucial role in Alzheimer's disease (AD) neurodegeneration. Understanding these Aβ-lipid interactions is key to developing AD therapies.

More Related Videos

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.8K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.2K

Related Experiment Videos

Last Updated: Apr 7, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.4K
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.8K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.2K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Amyloid-beta (Aβ) peptide aggregation is central to Alzheimer's disease (AD) pathogenesis.
  • Lipid homeostasis and specific lipids are implicated in neurodegenerative disorders.

Purpose of the Study:

  • To review the complex interplay between lipids and Aβ processing, clearance, and aggregation.
  • To discuss the contribution of lipid-Aβ interactions to neurotoxicity in AD.

Main Methods:

  • Literature review focusing on Aβ-lipid interactions.
  • Analysis of the role of membrane lipids, cholesterol, and apolipoprotein E in Aβ biogenesis and clearance.

Main Results:

  • Increased membrane cholesterol augments Aβ generation and correlates with AD progression.
  • Apolipoprotein E influences Aβ clearance and is a major genetic risk factor for AD.
  • Aβ interacts with lipid rafts, potentially forming pores and disrupting cellular calcium homeostasis.

Conclusions:

  • Aβ-lipid interactions at the cell membrane are likely triggers for the neurotoxic cascade in AD.
  • Specific lipids and apolipoprotein E are critical factors in AD pathogenesis and progression.